Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (571-580 of 776) with videos related to

Pageof 78
Sort By:
Journal of Alzheimer'S Disease : JAD|November 15, 2021
Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration NetworkValory N Pavlik, Samantha C Burnham, Joseph S Kass, et al.
Journal of Proteome Research|January 18, 2024
Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain RegionsMelanie T Odenkirk, Xueyun Zheng, Jennifer E Kyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adultsMichael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Hormones and Behavior|March 14, 2021
Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognitionSherilyn Tan, Tenielle Porter, Romola S Bucks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2022
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohortPratishtha Chatterjee, Steve Pedrini, James D Doecke, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2008
Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's diseaseKevin J Barnham, Vijaya B Kenche, Giuseppe D Ciccotosto, et al.
Brain Communications|September 4, 2024
Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adultsAnja Soldan, Jiangxia Wang, Corinne Pettigrew, et al.
Proteome Science|January 27, 2022
Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's diseaseScott B Laffoon, James D Doecke, Anne M Roberts, et al.
Plos One|April 29, 2011
Association of plasma Aß peptides with blood pressure in the elderlyJean-Charles Lambert, Jean Dallongeville, Kathryn A Ellis, et al.
Translational Psychiatry|February 27, 2018
Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burdenStephanie R Rainey-Smith, Gavin N Mazzucchelli, Victor L Villemagne, et al.
Pageof 78

Showing results (571-580 of 776) with videos related to

Sort By:
Pageof 78
Journal of Alzheimer'S Disease : JAD|November 15, 2021
Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration NetworkValory N Pavlik, Samantha C Burnham, Joseph S Kass, et al.
Journal of Proteome Research|January 18, 2024
Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain RegionsMelanie T Odenkirk, Xueyun Zheng, Jennifer E Kyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adultsMichael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Hormones and Behavior|March 14, 2021
Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognitionSherilyn Tan, Tenielle Porter, Romola S Bucks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2022
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohortPratishtha Chatterjee, Steve Pedrini, James D Doecke, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2008
Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's diseaseKevin J Barnham, Vijaya B Kenche, Giuseppe D Ciccotosto, et al.
Brain Communications|September 4, 2024
Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adultsAnja Soldan, Jiangxia Wang, Corinne Pettigrew, et al.
Proteome Science|January 27, 2022
Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's diseaseScott B Laffoon, James D Doecke, Anne M Roberts, et al.
Plos One|April 29, 2011
Association of plasma Aß peptides with blood pressure in the elderlyJean-Charles Lambert, Jean Dallongeville, Kathryn A Ellis, et al.
Translational Psychiatry|February 27, 2018
Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burdenStephanie R Rainey-Smith, Gavin N Mazzucchelli, Victor L Villemagne, et al.
Pageof 78